| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Functional Brands: Gross Margin Jumps 710 Basis Points Despite Volatile Listing | 1 | pulse2.com | ||
| FUNCTIONAL BRANDS Aktie jetzt für 0€ handeln | |||||
| 17.08. | Functional Brands Inc. GAAP EPS of -$0.06, revenue of $1.87M | 1 | Seeking Alpha | ||
| 17.08. | Functional Brands Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 13.07. | NSE - Functional Brands Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 1 | SEC Filings | ||
| 01.07. | Functional Brands Inc. - 8-K, Current Report | - | SEC Filings | ||
| 15.06. | Functional Brands faces Nasdaq delisting after stock falls below $0.10 | 2 | Investing.com | ||
| 15.06. | Functional Brands Inc.: Functional Brands Inc. Receives Nasdaq Staff Delisting Determination | 357 | Newsfile | Lake Oswego, Oregon--(Newsfile Corp. - June 15, 2026) - Functional Brands Inc. (NASDAQ: MEHA) (the "Company"), a leading innovator in wellness and performance products, announced today that on June... ► Artikel lesen | |
| 15.06. | Functional Brands Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 05.06. | Functional Brands Inc.: Functional Brands Inc. Announces Active Interest from Multiple Strategic Partners to Fund BullionFX | Alchemy Commercialization Following Pending Acquisition of the BFX Assets | 707 | Newsfile | Lake Oswego, Oregon--(Newsfile Corp. - June 5, 2026) - Functional Brands Inc. (NASDAQ: MEHA) ("MEHA" or the "Company") today announced advanced discussions with multiple strategic financial parties... ► Artikel lesen | |
| 04.06. | Functional Brands Inc.: Functional Brands Inc. Enters BullionFX | Alchemy Acquisition From a Position of Improving Financial Strength | 596 | Newsfile | Lake Oswego, Oregon--(Newsfile Corp. - June 4, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a U.S.-domiciled Nasdaq issuer, which is party to a binding agreement to acquire the assets of BullionFX... ► Artikel lesen | |
| 03.06. | Functional Brands shareholders approve reverse stock split | 4 | Investing.com | ||
| 03.06. | Functional Brands Inc.: Functional Brands Inc. Clears Barrier to $142.9 Million BullionFX | Alchemy Acquisition | 474 | Newsfile | Lake Oswego, Oregon--(Newsfile Corp. - June 3, 2026) - Functional Brands Inc. (NASDAQ: MEHA), announced that shareholders have voted to authorize the reverse stock split, removing an obstacle between... ► Artikel lesen | |
| 28.05. | Functional Brands Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 28.05. | Functional Brands Inc.: Functional Brands Announces Adjournment of Special Meeting of Stockholders | 517 | Newsfile | Lake Oswego, Oregon--(Newsfile Corp. - May 27, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced that the Company's Special... ► Artikel lesen | |
| 22.05. | Functional Brands to acquire BullionFX for $142.9M | 3 | Seeking Alpha | ||
| 22.05. | Functional Brands kündigt Übernahme von BullionFX-Assets im Wert von 142,9 Mio. US-Dollar an | 19 | Investing.com Deutsch | ||
| 22.05. | Functional Brands to acquire BullionFX assets for $142.9M | 2 | Investing.com | ||
| 22.05. | Functional Brands Inc.: Functional Brands Enters into Agreement to Acquire Alchemy, a Gold-Backed Blockchain Settlement Platform, in a $142.9 Million Transaction | 709 | Newsfile | Lake Oswego, Oregon--(Newsfile Corp. - May 22, 2026) - Functional Brands Inc. (NASDAQ: MEHA) ("Functional Brands" or the "Company") today announced the execution of a definitive agreement for the... ► Artikel lesen | |
| 19.05. | Functional Brands informiert Aktionäre über mögliche Übernahme von BullionFX-Vermögenswerten | 1 | Investing.com Deutsch | ||
| 18.05. | Functional Brands Inc. GAAP EPS of -$0.36, revenue of $1.65M | 1 | Seeking Alpha |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 48,040 | -1,17 % | Läutet der DAX das Ende der Sommerrallye ein? Bayer in prekärer Chartkonstellation | Geht dem deutschen Leitindex doch noch die Puste aus? Der frühe Dienstagshandel steht ganz im Zeichen einer leichten Konsolidierung. Gewinnmitnahmen dominieren das Handelsgeschehen. Noch sollte man... ► Artikel lesen | |
| MERCK KGAA | 137,95 | -0,07 % | JEFFERIES stuft MERCK KGAA auf 'Hold' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Merck KGaA von 129 auf 144 Euro angehoben, aber die Einstufung auf "Hold" belassen. Life Science stehe bei dem Pharmakonzern... ► Artikel lesen | |
| JUPITER NEUROSCIENCES | 6,250 | +0,81 % | Jupiter Neurosciences, Inc.: Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering | New York, Aug. 21, 2026 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter" or the "Company"), a clinical-stage biopharmaceutical company focused on central nervous system disorders... ► Artikel lesen | |
| NOVO NORDISK | 39,980 | +0,01 % | Mehr als 7 Millionen Patienten allein in den USA: Mesoblast erreicht entscheidenden Phase-III-Meilenstein | ||
| ETON PHARMACEUTICALS | 63,35 | -0,19 % | Biotech Stocks At 52-Week Highs - Eton Pharmaceuticals +44%, DXCM, ORKA, CON, ATAI | INDIANAPOLIS (dpa-AFX) - The following biotech stocks reached 52-week highs on August 14, 2026, following positive quarterly reports or an announced upcoming acquisition. Eton Pharmaceuticals... ► Artikel lesen | |
| PFIZER | 24,000 | -0,12 % | Gewinner der Börsengeschichte: Nicht Pfizer: Diese US-Pharma-Aktie schlägt mit +4.693.845 % Rendite sogar Exxon | © Foto: DALLE (KI-Bild) - OpenAIPharma schlägt Öl: Eine Studie zu 29.078 US-Aktien zeigt, dass CVS Health im Zeitraum von 1928 bis 2023 eine höhere Gesamtrendite erzielte als Exxon. Die Hintergründe... ► Artikel lesen | |
| MERCK & CO | 130,78 | +0,14 % | Potenzial trotz Mega-Rallye: Merck & Co. nach 40-%-Rallye: Morgan Stanley zündet den Kursziel-Turbo! | © Foto: Rafael Henrique - SOPA Images via ZUMA Press WireDie Aktie von Merck Sharp & Dohme (MSD) ist 2026 bereits 40 Prozent gestiegen. Doch Morgan Stanley hebt das Kursziel massiv an - und erklärt... ► Artikel lesen | |
| ELI LILLY | 1.075,00 | +0,04 % | 332 Millionen Menschen leiden an Depressionen - jetzt beginnt Big Pharma das Milliardenrennen um neue Therapien | ||
| BIOHAVEN | 13,850 | 0,00 % | Biohaven Ltd.: Biohaven Reports Recent Business Developments and Second Quarter 2026 Financial Results | First extracellular protein degraders in the clinic demonstrate rapid and robust pharmacodynamic effects and compelling safety in nearly 200 individuals dosed... ► Artikel lesen | |
| SCHOTT PHARMA | 23,050 | +1,32 % | Aktien Frankfurt: Dax schwächelt - Öl und Anleihemarkt belasten | FRANKFURT (dpa-AFX) - Der Dax tut sich nach seinem in der vergangenen Woche erreichten Rekordhoch weiter schwer. Schwache Übersee-Vorgaben, steigende Ölpreise und höhere Anleiherenditen dämpfen am... ► Artikel lesen | |
| BRIGHT MINDS BIOSCIENCES | 77,42 | 0,00 % | Levoit and Cosori: 5 Back to School Wellness Heroes for the Bright Minds of Tomorrow | DUBAI, UAE, Aug. 21, 2026 /PRNewswire/ -- Levoit and Cosori unveil five smart home solutions to tackle back to school stresses: polluted indoor air, relentless AC dryness, post snack floor... ► Artikel lesen | |
| AQUESTIVE THERAPEUTICS | 4,650 | -0,21 % | Aquestive Therapeutics, Inc.: Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update | Successfully completed human factors validation study and pharmacokinetic study for Anaphylm (dibutepinephrine) sublingual filmRemains on track to resubmit Anaphylm NDA to the FDA in Q3 2026Continues... ► Artikel lesen | |
| GENERATE BIOMEDICINES | 16,110 | -0,06 % | Cathie Woods Biotech-Offensive lenkt den Blick auf datengetriebene Healthcare-Unternehmen - Emyria baut klinische Präsenz aus | ||
| SANOFI | 78,44 | +0,14 % | UBS stuft SANOFI auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Sanofi mit einem Kursziel von 78 Euro auf "Neutral" belassen. Mit Blick auf den Antikörper-Wirkstoff Lunsekimig gegen Asthma... ► Artikel lesen | |
| LB PHARMACEUTICALS | 47,500 | -0,25 % | LB Pharmaceuticals Inc: LB Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update | Announced accelerated timing of topline data readout from the pivotal Phase 3 NOVA-2 trial of LB-102 in schizophrenia in the first half of 2027 Announced plans for pipeline expansion of LB-102 into... ► Artikel lesen |